Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Certain topical drugs can regrow hair in mice.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Tofacitinib is a promising treatment for children with rheumatic diseases.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

Nirogacestat can cause severe skin issues like hidradenitis suppurativa.

A woman developed Cushing syndrome and adrenal insufficiency from using fluticasone and ritonavir together.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Enzyme booster SULT1A1 greatly enhances hair regrowth with minoxidil.